MedTrace Logo

Safety Study of the Aethlon Hemopurifier

NCT02215902 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-03-14

No results posted yet for this study

Summary

Primary Objectives:

To demonstrate the safety of the Aethlon Hemopurifier® when used in extracorporeal blood purification.

Secondary Objectives:

To quantify the number of viral copies captured by the Aethlon Hemopurifier® during the first and last Hemopurifier treatments using elution methods developed by Aethlon Medical Inc.

To measure changes in viral load in patients before and after treatment with the Aethlon Hemopurifier®.

Conditions

Interventions

DEVICE

Affinity plasmapheresis

Insert investigational affinity plasma filter into hemodialysis circuit during routine hemodialysis treatments.

Sponsors & Collaborators

  • Aethlon Medical Inc.

    lead INDUSTRY

Principal Investigators

  • Felicia B Ricks, RD CS-R LD · DaVita Clincal Research

  • Ronald Ralph, M. D. FASN · Kidney Associates, PLLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-03-10
Completion
2017-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02215902 on ClinicalTrials.gov